New APMA Resources on Wound Care Documentation
APMA has two new resources to help with wound care documentation: a webinar hosted by APMA RUC Advisor, Susan Walsh, DPM, MBA, and an article in APMA News from Coding Committee member Jonathon Huey, DPM, and Dr. Walsh.
Read More
APMA Pushes for Changes to NPUECM
APMA has submitted a letter to Acumen and CMS regarding the development of the Non-Pressure Ulcer Episode-Based Cost Measure (NPUECM) and requested a meeting to advocate for podiatrists.
Read More
AMA National Advocacy Conference
APMA staff participated in the AMA National Advocacy Conference that focused on how to advance shared legislative priorities, including meaningful Medicare Physician Payment Reform, reducing administrative burdens caused by prior authorization, and protecting and strengthening access to Medicaid. Following policy briefings from members of Congress, CMS officials, and national health-care leaders, APMA staff took these priorities directly to meetings on Capitol Hill.
Read More
Alliance Advocacy Impact Report
APMA’s advocacy impact is strengthened through active participation in the Alliance of Wound Care Stakeholders (Alliance). We are proud to share the Alliance’s 2025 Advocacy Impact Report, which highlights the collective progress made to advance fair reimbursement, appropriate coverage, and equitable patient access.
Read More
APMA Position Statement on AI
APMA adopted a formal position statement on artificial intelligence (AI) and submitted comments to HHS in response to its national Request for Information on the use of AI in clinical care. APMA emphasized that AI should support, not replace, physician judgment. We also raised concerns that opaque algorithms and broad datasets can lead to inappropriate denials, downcoding, and delays in patient care.
Read More
APMA Supports State Legislative Efforts
APMA continues to work closely with state components on legislative strategy, stakeholder engagement, testimony development, grassroots advocacy, and regulatory outreach across multiple states, including Tennessee, Massachusetts, and Mississippi. Several states are also actively considering adoption of the IPMLC, including Arizona, Florida, Iowa, Maryland, and Ohio.
Read More
DME Enrollment Moratorium
Last week, CMS announced a moratorium on enrollment (and enrollment expansion) for certain medical supply companies. This enrollment moratorium affects medical supply companies whose principal function is to furnish DMEPOS supplies, which does not represent most physician suppliers.
Read More
CMS Alert: MBI Lookup Tool Monitoring
In the MLN Connects Newsletter for February 26, CMS highlighted that it has identified fraud involving stolen Medicare Beneficiary Identifiers (MBIs) and is increasing monitoring of the Medicare Administrative Contractor (MAC) MBI lookup tool.
Read More
APMA Fights to Protect Seniors
APMA recently submitted testimony to the Senate Committee on Aging for its hearing titled "The Doctor Is Out How Washington’s Rules Drove Physicians Out of Medicine," highlighting how excessive prior authorization requirements in Medicare Advantage are delaying care and increasing administrative burdens for podiatrists.
Read More
VHA Workforce Cuts
APMA submitted comments to the House Committee on Veterans' Affairs expressing concern that the ongoing VHA reorganization and recent workforce reductions are threatening veterans' access to timely foot and ankle care. With approximately 30,000 VA positions eliminated in 2025 and new staffing caps in place, shortages are straining critical limb-preservation programs and limiting care for clinically complex veterans.
Read More
Reporting Postoperative Visits
Last week, CMS reminded practitioners in nine states that they are required to report postoperative evaluation and management visits provided to Medicare patients if the practitioner practices in a group of 10 or more practitioners.
Read More
Co-Signed Notes for Diabetic Shoes
Following sustained advocacy and multiple rounds of direct communication with CMS and the DME MACs, APMA has secured critical clarification regarding coverage criteria for therapeutic shoes for persons with diabetes. We have confirmed that co-signed notes are not required when specific documentation standards are met.
Read More
